Phase 2 Study of the Assessment of Pulmonary Function, Safety, Tolerability, and PK of Zileuton Injection in Patients With Chronic Stable Asthma
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2008
At a glance
- Drugs Zileuton (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Critical Therapeutics
- 03 Jun 2008 Top-line results reported in a Critical Therapeutics media release.
- 20 Mar 2008 Status change from in progress to completed.
- 09 Jan 2008 Status change from recruiting to in progress.